CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 4,398	$ 4,924
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of premiums and accretion of discounts on investment securities, net	536	958
Depreciation and amortization	204	212
Stock-based compensation	16	11
Provision for loan losses	625	0
Net other-than-temporary impairment losses on investment securities	0	24
Gains on sales of investment securities, net	(1,415)	(343)
Loans originated for resale	(2,168)	(7,605)
Proceeds from sale of loans held for sale	2,204	8,460
Gains on sale of loans held for sale	(36)	(138)
Decrease in accrued interest receivable	461	426
Decrease in prepaid FDIC insurance assessments	0	286
Increase in cash surrender value of bank-owned life insurance	(255)	(274)
Life insurance death benefit	0	(291)
Decrease in other assets	1,588	909
(Decrease) increase in other liabilities	(31)	609
Net cash provided by operating activities	6,127	8,168
Cash flows from investing activities:
Investment securities available-for-sale: Purchases	(10,397)	(37,204)
Investment securities available-for-sale: Sales	50,611	45,006
Investment securities available-for-sale: Maturities, calls and principal repayments	6,999	14,121
Investment securities held-to-maturity: Purchases	0	(4,996)
Investment securities held-to-maturity: Maturities and principal repayments	890	689
Net redemption (purchases) of restricted investment in bank stocks	0	(2)
Net (increase) decrease in loans	(26,911)	10,044
Purchases of premises and equipment	(350)	(182)
Proceeds from bank-owned life insurance death benefits	0	592
Net cash provided by investing activities	20,842	28,068
Cash flows from financing activities:
Net decrease in deposits	(2,120)	(24,699)
Cash dividends on preferred stock	(28)	(28)
Cash dividends on common stock	(1,228)	(899)
Issuance cost of common stock	(3)	(3)
Proceeds from exercise of stock options	0	10
Net cash used in financing activities	(3,379)	(25,619)
Net increase in cash and cash equivalents	23,590	10,617
Cash and cash equivalents at beginning of period	82,692	106,138
Cash and cash equivalents at end of period	106,282	116,755
Supplemental disclosures of cash flow information:
Cash payments for: Interest paid on deposits and borrowings	2,723	2,727
Cash payments for: Income taxes	500	0
Supplemental disclosures of non-cash investing activities:
Trade date accounting settlements for investments, net	0	650
Transfer of loans to other real estate owned	0	236
Transfer from investment securities available-for-sale to investment securities held-to-maturity	$ 0	$ 15,936